Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Exercise of Options and Total Voting Rights

1st Oct 2025 12:00

RNS Number : 6476B
Ilika plc
01 October 2025
 

1 October 2025

 

Ilika plc

("Ilika", the "Group". or the "Company")

 

Exercise of Options, Issue of New Ordinary Shares and Total Voting Rights

 

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that, following the vesting and exercise of options under the Company's share option schemes, it has issued 30,000 new ordinary shares of 1p each in the Company ("New Ordinary Shares"). Accordingly, the Company has applied to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur on or around 8.00 a.m. on 6 October 2025.

 

Total Voting Rights

 

Following Admission, the Company's issued share capital will comprise 180,832,175 Ordinary Shares and that number may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury. 

 

For more information contact:

 

 

Ilika Plc Graeme Purdy, Chief Executive

Jason Stewart, Chief Financial Officer

www.ilika.com

Via FTI Consulting

 

 

Cavendish Capital Markets Limited (Nomad and Broker) Peter Lynch

Neil McDonald

+44 (0)131 220 9772

+44 (0)131 220 9771

 

 

FTI Consulting (Comms Advisors)

Ben Brewerton

Elizabeth Adams

Dwight Burden

[email protected]

 

 

 

About Ilika plc - https://www.ilika.com

 

Ilika is a global expert in the development of solid state battery technology for electric vehicles, medical devices and consumer appliances. The Company's pioneering next-generation technologies aim to provide scalable, affordable alternatives to conventional batteries, to industries which need to incorporate a smaller, lighter, and safer power source in their products.

 

The Company has two product lines. Its Stereax batteries are designed for powering miniature medical implants, industrial wireless sensors and Internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

Through its licensing business model, Ilika supplies its IP portfolio to both OEMs and manufacturing partners in exchange for a license fee and future royalties

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFSFFSFEISELS

Related Shares:

Ilika Plc
FTSE 100 Latest
Value9,563.61
Change80.03